These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction. Nyström T, Nygren A, Sjöholm A. Clin Sci (Lond); 2006 Jun; 110(6):673-81. PubMed ID: 16466346 [Abstract] [Full Text] [Related]
3. Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C. Antoniades C, Tousoulis D, Tountas C, Tentolouris C, Toutouza M, Vasiliadou C, Tsioufis C, Toutouzas P, Stefanadis C. Diabet Med; 2004 Jun; 21(6):552-8. PubMed ID: 15154938 [Abstract] [Full Text] [Related]
4. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial. Caballero AE, Saouaf R, Lim SC, Hamdy O, Abou-Elenin K, O'Connor C, Logerfo FW, Horton ES, Veves A. Metabolism; 2003 Feb; 52(2):173-80. PubMed ID: 12601628 [Abstract] [Full Text] [Related]
5. Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction. Meyer MF, Lieps D, Schatz H, Pfohl M. Microvasc Res; 2008 May; 76(1):61-5. PubMed ID: 18448131 [Abstract] [Full Text] [Related]
7. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus. Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA. Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467 [Abstract] [Full Text] [Related]
8. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6). Mohan V, Deepa R, Velmurugan K, Premalatha G. Diabet Med; 2005 Jul; 22(7):863-70. PubMed ID: 15975100 [Abstract] [Full Text] [Related]
11. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy. Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G. Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364 [Abstract] [Full Text] [Related]
15. Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients. Xiang GD, Sun HL, Zhao LS. Diabetes Res Clin Pract; 2007 May; 76(2):199-206. PubMed ID: 17023086 [Abstract] [Full Text] [Related]
16. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome. Linnemann B, Voigt W, Nobel W, Janka HU. Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):127-34. PubMed ID: 16636979 [Abstract] [Full Text] [Related]
17. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease. Settergren M, Böhm F, Rydén L, Pernow J. Eur Heart J; 2008 Jul; 29(14):1753-60. PubMed ID: 18441323 [Abstract] [Full Text] [Related]
19. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H. J Am Coll Cardiol; 2005 May 17; 45(10):1622-30. PubMed ID: 15893178 [Abstract] [Full Text] [Related]
20. Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus. Tesauro M, Rizza S, Iantorno M, Campia U, Cardillo C, Lauro D, Leo R, Turriziani M, Cocciolillo GC, Fusco A, Panza JA, Scuteri A, Federici M, Lauro R, Quon MJ. Metabolism; 2007 Mar 17; 56(3):413-9. PubMed ID: 17292732 [Abstract] [Full Text] [Related] Page: [Next] [New Search]